Biotechnology company focusing on immune-driven medicine
Issues related to the Medicare Multi-Cancer Early Detection Screening Coverage Act of 2021 (S. 1873 & H.R. 1946). Federal funding support for cellular immunity research and utilization; including Fiscal Year 2022 (H.R. 4502) and Fiscal Year 2023 Labor, Health and Human Services, and Education, and Related Agencies appropriations issues (S. 4659; H.R. 8295), Fiscal Year 2023 Department of Agriculture, Rural Development, Food and Drug Administration, and Related Agencies appropriations issues (S. 4661; H.R. 8239; H.R. 8294), and the Consolidated Appropriations Act, 2023 (P.L. 117-328). Issues related to lab analysis and review of diagnostics and lab developed tests, including the Verifying Accurate Leading-edge IVCT Development (VALID) Act of 2021 (H.R. 4128/S. 2209), the Food and Drug Administration Safety and Landmark Advancements Act of 2022 (S. 4348), and the Consolidated Appropriations Act, 2023 (P.L. No: 117-328).
MMM - Medicare/Medicaid BUD - Budget/Appropriations HCR - Health Issues
2 - HOUSE OF REPRESENTATIVES 1 - SENATE 2 - HOUSE OF REPRESENTATIVES 1 - SENATE 136 - Centers For Medicare and Medicaid Services (CMS) 34 - Health & Human Services, Dept of (HHS) 2 - HOUSE OF REPRESENTATIVES 1 - SENATE 12 - White House Office
ARNOLD & PORTER KAYE SCHOLER LLP
601 Massachusetts Ave. NW, Washington, DC, 20001, US
PETER DUYSHART CASEY BROUHARD PARI MODY BOBBY MCMILLIN KRISTINE BLACKWOOD EUGENIA PIERSON PETER DUYSHART CASEY BROUHARD PARI MODY BOBBY MCMILLIN KRISTINE BLACKWOOD EUGENIA PIERSON PETER DUYSHART CASEY BROUHARD PARI MODY BOBBY MCMILLIN KRISTINE BLACKWOOD EUGENIA PIERSON